ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Recompetition Of Human Tissue Network

June 30, 1989

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

In Brief: Karmanos Institute Names Four To Faculty; $1.5M Donated To Kaplan Cancer Center

September 11, 1998

Reexamine Mandates, Samuels Suggests

February 17, 1984

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002